Author D. Kozielewicz
Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin
Przegl Epidemiol 2017;71(4):555-569
Article Impact of selected predictive factors on sustained virologic response in HCV genotype 4 infected patients treated with pegylated interferon alpha and ribavirin
Przegl Epidemiol 2017;71(2):177-189
Przygotowanie pacjentów zakażonych HCV do terapii trójlekowej z zastosowaniem inhibitorów proteazy pierwszej generacji
Przegl Epidemiol 2013;67(4):713-716
Preparation of HCV infected patients to the triple therapy with first generation protease inhibitors
Przegl Epidemiol 2013;67(4):623-628
Efficacy of triple therapy in patients not treated and patients previously treated ineffectively
Przegl Epidemiol 2012;66(1):49-54
Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha
Przegl Epidemiol 2008;62(1):93-100
Prevalence of borreliosis among forestry workers in Kujawsko-Pomorskie voivodeship
Przegl Epidemiol 2007;61(1):67-71
| eISSN: | 2545-1898 |
| ISSN: | 0033-2100 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
